Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 3 |
GO:0043226 | organelle | 2 | 3 |
GO:0043227 | membrane-bounded organelle | 3 | 3 |
GO:0043229 | intracellular organelle | 3 | 3 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
Related structures:
AlphaFold database: A4HIT3
Term | Name | Level | Count |
---|---|---|---|
GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation | 8 | 3 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 3 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 9 | 3 |
GO:0006396 | RNA processing | 6 | 3 |
GO:0006399 | tRNA metabolic process | 7 | 3 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 3 |
GO:0006807 | nitrogen compound metabolic process | 2 | 3 |
GO:0008033 | tRNA processing | 8 | 3 |
GO:0008152 | metabolic process | 1 | 3 |
GO:0008380 | RNA splicing | 7 | 3 |
GO:0009987 | cellular process | 1 | 3 |
GO:0016070 | RNA metabolic process | 5 | 3 |
GO:0034470 | ncRNA processing | 7 | 3 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 3 |
GO:0034660 | ncRNA metabolic process | 6 | 3 |
GO:0043170 | macromolecule metabolic process | 3 | 3 |
GO:0044237 | cellular metabolic process | 2 | 3 |
GO:0044238 | primary metabolic process | 2 | 3 |
GO:0046483 | heterocycle metabolic process | 3 | 3 |
GO:0071704 | organic substance metabolic process | 2 | 3 |
GO:0090304 | nucleic acid metabolic process | 4 | 3 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 3 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 3 |
GO:0005488 | binding | 1 | 3 |
GO:0097159 | organic cyclic compound binding | 2 | 3 |
GO:1901363 | heterocyclic compound binding | 2 | 3 |
GO:0000213 | tRNA-intron endonuclease activity | 6 | 1 |
GO:0003824 | catalytic activity | 1 | 1 |
GO:0004518 | nuclease activity | 4 | 1 |
GO:0004519 | endonuclease activity | 5 | 1 |
GO:0004521 | RNA endonuclease activity | 5 | 1 |
GO:0004540 | RNA nuclease activity | 4 | 1 |
GO:0004549 | tRNA-specific ribonuclease activity | 5 | 1 |
GO:0016787 | hydrolase activity | 2 | 1 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 1 |
GO:0016892 | RNA endonuclease activity, producing 3'-phosphomonoesters | 6 | 1 |
GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters | 6 | 1 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 1 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 1 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 28 | 32 | PF00656 | 0.487 |
CLV_NRD_NRD_1 | 121 | 123 | PF00675 | 0.399 |
CLV_NRD_NRD_1 | 72 | 74 | PF00675 | 0.455 |
CLV_PCSK_KEX2_1 | 11 | 13 | PF00082 | 0.516 |
CLV_PCSK_KEX2_1 | 72 | 74 | PF00082 | 0.455 |
CLV_PCSK_PC1ET2_1 | 11 | 13 | PF00082 | 0.527 |
DEG_SCF_FBW7_2 | 126 | 133 | PF00400 | 0.385 |
DOC_CKS1_1 | 127 | 132 | PF01111 | 0.385 |
DOC_PP4_FxxP_1 | 102 | 105 | PF00568 | 0.623 |
DOC_USP7_MATH_1 | 87 | 91 | PF00917 | 0.448 |
DOC_USP7_MATH_2 | 13 | 19 | PF00917 | 0.510 |
DOC_WW_Pin1_4 | 126 | 131 | PF00397 | 0.382 |
DOC_WW_Pin1_4 | 33 | 38 | PF00397 | 0.438 |
DOC_WW_Pin1_4 | 50 | 55 | PF00397 | 0.553 |
LIG_14-3-3_CanoR_1 | 116 | 126 | PF00244 | 0.381 |
LIG_14-3-3_CanoR_1 | 72 | 76 | PF00244 | 0.422 |
LIG_BIR_III_2 | 31 | 35 | PF00653 | 0.414 |
LIG_FHA_2 | 84 | 90 | PF00498 | 0.332 |
LIG_LIR_Apic_2 | 100 | 105 | PF02991 | 0.619 |
LIG_LIR_Gen_1 | 3 | 9 | PF02991 | 0.570 |
LIG_LIR_Nem_3 | 3 | 7 | PF02991 | 0.590 |
LIG_NRBOX | 39 | 45 | PF00104 | 0.333 |
LIG_SH2_CRK | 139 | 143 | PF00017 | 0.345 |
LIG_SH2_STAP1 | 139 | 143 | PF00017 | 0.459 |
LIG_SH2_STAT5 | 139 | 142 | PF00017 | 0.411 |
LIG_SH2_STAT5 | 4 | 7 | PF00017 | 0.616 |
LIG_SH2_STAT5 | 64 | 67 | PF00017 | 0.405 |
LIG_SH3_3 | 124 | 130 | PF00018 | 0.373 |
LIG_SH3_3 | 31 | 37 | PF00018 | 0.395 |
LIG_SUMO_SIM_anti_2 | 107 | 113 | PF11976 | 0.468 |
LIG_SUMO_SIM_anti_2 | 3 | 9 | PF11976 | 0.488 |
LIG_TYR_ITIM | 137 | 142 | PF00017 | 0.316 |
MOD_CDC14_SPxK_1 | 53 | 56 | PF00782 | 0.442 |
MOD_CDK_SPxK_1 | 50 | 56 | PF00069 | 0.436 |
MOD_CK1_1 | 107 | 113 | PF00069 | 0.400 |
MOD_CK1_1 | 18 | 24 | PF00069 | 0.609 |
MOD_CK1_1 | 36 | 42 | PF00069 | 0.414 |
MOD_CK2_1 | 83 | 89 | PF00069 | 0.384 |
MOD_GlcNHglycan | 106 | 109 | PF01048 | 0.474 |
MOD_GlcNHglycan | 25 | 30 | PF01048 | 0.518 |
MOD_GSK3_1 | 122 | 129 | PF00069 | 0.419 |
MOD_GSK3_1 | 15 | 22 | PF00069 | 0.661 |
MOD_GSK3_1 | 83 | 90 | PF00069 | 0.468 |
MOD_N-GLC_2 | 119 | 121 | PF02516 | 0.362 |
MOD_NEK2_1 | 137 | 142 | PF00069 | 0.379 |
MOD_NEK2_1 | 43 | 48 | PF00069 | 0.463 |
MOD_NEK2_1 | 71 | 76 | PF00069 | 0.332 |
MOD_NMyristoyl | 1 | 7 | PF02799 | 0.503 |
MOD_OFUCOSY | 115 | 121 | PF10250 | 0.377 |
MOD_PKA_1 | 122 | 128 | PF00069 | 0.437 |
MOD_PKA_2 | 71 | 77 | PF00069 | 0.478 |
MOD_Plk_1 | 19 | 25 | PF00069 | 0.431 |
MOD_Plk_4 | 107 | 113 | PF00069 | 0.405 |
MOD_Plk_4 | 122 | 128 | PF00069 | 0.377 |
MOD_Plk_4 | 3 | 9 | PF00069 | 0.583 |
MOD_ProDKin_1 | 126 | 132 | PF00069 | 0.380 |
MOD_ProDKin_1 | 33 | 39 | PF00069 | 0.429 |
MOD_ProDKin_1 | 50 | 56 | PF00069 | 0.552 |
TRG_ENDOCYTIC_2 | 139 | 142 | PF00928 | 0.330 |
TRG_ENDOCYTIC_2 | 4 | 7 | PF00928 | 0.528 |
TRG_ER_diArg_1 | 71 | 73 | PF00400 | 0.305 |
TRG_Pf-PMV_PEXEL_1 | 63 | 67 | PF00026 | 0.279 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4G2 | Leptomonas seymouri | 57% | 91% |
A0A1X0P2F0 | Trypanosomatidae | 39% | 97% |
A0A3S7X3W7 | Leishmania donovani | 81% | 100% |
A4I635 | Leishmania infantum | 81% | 100% |
C9ZRF4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 32% | 89% |
E9B1C0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 80% | 100% |
Q4Q6U4 | Leishmania major | 79% | 100% |